Advertisement
Screener

IRONWOOD PHARMACEUTICALS, INC. (IRWD) Proceeds from Sale of Available-for-sale Securities

IRONWOOD PHARMACEUTICALS, INC. Proceeds from Sale of Available-for-sale Securities

IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Proceeds from Sale of Available-for-sale Securities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-22.

Discontinued › Cash Flow › Investing Activities

us-gaap:ProceedsFromSaleOfAvailableForSaleSecurities · last filed 2018-02-22

  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-12-31 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-09-30 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-06-30 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for the quarter ending 2017-03-31 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for fiscal 2017 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for fiscal 2016 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for fiscal 2015 was $0.00.
  • IRONWOOD PHARMACEUTICALS, INC. proceeds from sale of available-for-sale securities for fiscal 2014 was $0.00.
Period endProceeds from Sale of Available-for-sale Securities 3 monthProceeds from Sale of Available-for-sale Securities 6 monthProceeds from Sale of Available-for-sale Securities 9 monthProceeds from Sale of Available-for-sale Securities 12 month
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$0.00
derived: sum of 2 quarters · filed 2018-02-22
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
10-K · filed 2018-02-22
2017-09-30$0.00
10-Q · filed 2017-11-02
$0.00
derived: sum of 2 quarters · filed 2017-11-02
$0.00
10-Q · filed 2017-11-02
$0.00
derived: sum of 4 quarters · filed 2018-02-22
2017-06-30$0.00
10-Q · filed 2017-08-03
$0.00
10-Q · filed 2017-08-03
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
derived: sum of 4 quarters · filed 2018-02-22
2017-03-31$0.00
10-Q · filed 2017-05-08
$0.00
derived: sum of 2 quarters · filed 2018-02-22
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
derived: sum of 4 quarters · filed 2018-02-22
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$0.00
derived: sum of 2 quarters · filed 2018-02-22
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
10-K · filed 2018-02-22
2016-09-30$0.00
10-Q · filed 2017-11-02
$0.00
derived: sum of 2 quarters · filed 2017-11-02
$0.00
10-Q · filed 2017-11-02
$0.00
derived: sum of 4 quarters · filed 2018-02-22
2016-06-30$0.00
10-Q · filed 2017-08-03
$0.00
10-Q · filed 2017-08-03
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
derived: sum of 4 quarters · filed 2018-02-22
2016-03-31$0.00
10-Q · filed 2017-05-08
$0.00
derived: sum of 2 quarters · filed 2018-02-22
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
derived: sum of 4 quarters · filed 2018-02-22
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
$0.00
derived: sum of 2 quarters · filed 2018-02-22
$0.00
derived: sum of 3 quarters · filed 2018-02-22
$0.00
10-K · filed 2018-02-22
2015-09-30$0.00
10-Q · filed 2016-11-07
$0.00
derived: sum of 2 quarters · filed 2016-11-07
$0.00
10-Q · filed 2016-11-07
$0.00
derived: sum of 4 quarters · filed 2017-02-22
2015-06-30$0.00
10-Q · filed 2015-08-07
$0.00
10-Q · filed 2016-08-08
$0.00
derived: sum of 3 quarters · filed 2017-02-22
$0.00
derived: sum of 4 quarters · filed 2017-02-22
2015-03-31$0.00
10-Q · filed 2016-05-10
$0.00
derived: sum of 2 quarters · filed 2017-02-22
$0.00
derived: sum of 3 quarters · filed 2017-02-22
$0.00
derived: sum of 4 quarters · filed 2017-02-22
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22
$0.00
derived: sum of 2 quarters · filed 2017-02-22
$0.00
derived: sum of 3 quarters · filed 2017-02-22
$0.00
10-K · filed 2017-02-22
2014-09-30$0.00
10-Q · filed 2015-11-05
$0.00
derived: sum of 2 quarters · filed 2015-11-05
$0.00
10-Q · filed 2015-11-05
$0.00
derived: sum of 4 quarters · filed 2016-02-19
2014-06-30$0.00
10-Q · filed 2015-08-07
$0.00
10-Q · filed 2015-08-07
$0.00
derived: sum of 3 quarters · filed 2016-02-19
$0.00
derived: sum of 4 quarters · filed 2016-02-19
2014-03-31$0.00
10-Q · filed 2015-05-06
$0.00
derived: sum of 2 quarters · filed 2016-02-19
$0.00
derived: sum of 3 quarters · filed 2016-02-19
$0.00
derived: sum of 4 quarters · filed 2016-02-19
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
$0.00
derived: sum of 2 quarters · filed 2016-02-19
$0.00
derived: sum of 3 quarters · filed 2016-02-19
$0.00
10-K · filed 2016-02-19
2013-09-30$0.00
10-Q · filed 2014-11-05
$0.00
derived: sum of 2 quarters · filed 2014-11-05
$0.00
10-Q · filed 2014-11-05
$51.00M
derived: sum of 4 quarters · filed 2015-02-18
2013-06-30$0.00
10-Q · filed 2014-08-05
$0.00
10-Q · filed 2014-08-05
$51.00M
derived: sum of 3 quarters · filed 2015-02-18
$51.00M
derived: sum of 4 quarters · filed 2015-02-18
2013-03-31$0.00
10-Q · filed 2014-04-29
$51.00M
derived: sum of 2 quarters · filed 2015-02-18
$51.00M
derived: sum of 3 quarters · filed 2015-02-18
$51.00M
derived: sum of 4 quarters · filed 2015-02-18
2012-12-31$51.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18
$51.00M
derived: sum of 2 quarters · filed 2015-02-18
$51.00M
derived: sum of 3 quarters · filed 2015-02-18
$51.00M
10-K · filed 2015-02-18
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
$0.00
derived: sum of 2 quarters · filed 2013-10-28
$0.00
10-Q · filed 2013-10-28
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08
$0.00
10-Q · filed 2013-08-08
2012-03-31$0.00
10-Q · filed 2013-04-23
2011-12-31$10.00M
10-K · filed 2014-02-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Verastem, Inc. (VSTM)United States$0.706B-1.71
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Neurogene Inc. (NGNE)$0.625B-4.46
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78